Sort by
Refine Your Search
-
for SecondmentNoClosing Date24-Apr-2026JD_Param11YesJD_Param12Yes UCL is a diverse global community of world-class academics, students, industry links, external partners, and alumni. Our powerful collective of individuals
-
About us UCL is a diverse global community of world-class academics, students, industry links, external partners, and alumni. Our powerful collective of individuals and institutions work together to
-
About us Further Information about the UCL Cancer Institute can be found on our website https://www.ucl.ac.uk/cancer/ . About the role We are looking for a talented and enthusiastic Research
-
https://www.ucl.ac.uk/work-at-ucl/rewards-and-benefits to find out more. Our commitment to Equality, Diversity and Inclusion We particularly encourage applications from candidates who are likely to be
-
of Tübingen and part of the Developmental Computational Psychiatry research group, which is located both at Tübingen and the Max Planck UCL Centre for Computational Psychiatry and Ageing Research in London. You
-
-£76,244Contract TypePermanentWorking TypeHybridAvailable for SecondmentNoClosing Date03-Mar-2026JD_Param11YesJD_Param12Yes UCL is a radically different university. Founded in 1826 in the heart of London, we were
-
(abarr@ic.ac.uk ). The Barr group studies the mechanisms that control entry into and exit from the cell cycle, with a focus on quiescence entry and exit. A major goal of our research is to understand how
-
that control entry into and exit from the cell cycle, with a focus on quiescence entry and exit. A major goal of our research is to understand how these mechanisms become dysregulated in cancer cells, how
-
infection. Mutations in TPL-2 can lead to cancer through it’s ability to promote cell proliferation and survival. The activity of TPL-2 is normally tightly controlled and active TPL-2 is rapidly degraded
-
tightly controlled and active TPL-2 is rapidly degraded to limit the activation of downstream pathways. We previously demonstrated that TPL-2 is a nuclear-cytoplasmic shuttling protein that undergoes